SJ3366

Known as: 1-(3-Cyclopenten-1-yl)methyl-6-(3,5-dimethylbenzoyl)-5-ethyl-2,4-pyrimidinedione, SJ-3366 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2001-2008
0120012008

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Seventy-three analogs of SJ-3366 (1-(3-cyclopenten-1-ylmethyl)-5-ethyl-6-(3,5-dimethylbenzoyl)-2,4(1H,3H)-pyrimidinedione) were… (More)
Is this relevant?
2004
2004
This paper reports the synthesis and the antiviral activities of a series of 6-arylvinyl substituted analogues of SJ-3366, a… (More)
Is this relevant?
Review
2002
Review
2002
The increased incidence of HIV/AIDS disease in women aged 15 - 49 years has identified the urgent need for a female-controlled… (More)
Is this relevant?
Review
2002
Review
2002
The potential of a large variety of new compounds and new strategies for the treatment of virtually all major virus infections… (More)
Is this relevant?
Review
2002
Review
2002
Sam Jin is investigating SJ-3366, a non-nucleoside reverse transcriptase inhibitor (NNRTI), for the potential treatment of HIV… (More)
Is this relevant?
2001
2001
We have identified and characterized a potent new nonnucleoside reverse transcriptase (RT) inhibitor (NNRTI) of human… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?